Prot #905-UC-050: A Randomized, Double-Blind, Parallel, Placebo-Controlled, Phase 4, Multi-center Study to Assess Efficacy and Safety of VESIcare® (Solifenacin Succinate) to Improve Urinary Continence of Subjects after Robotic Assisted Radical Prostatecto

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date1/3/131/3/16

    Funding

    • Astellas Pharma Global Development, Inc. (Prot #905-UC-050)